Literature DB >> 11839591

Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis.

Joanne M Upston1, Xianwa Niu, Andrew J Brown, Ryuichi Mashima, Hongjie Wang, Revathy Senthilmohan, Anthony J Kettle, Roger T Dean, Roland Stocker.   

Abstract

Oxidative modification of low-density lipoprotein is thought to promote arterial lipid accumulation and atherogenesis. Previous studies reported on the presence of certain lipid or protein oxidation products in lesions, although a systematic investigation measuring several oxidation parameters and the accumulation of nonoxidized lipids and antioxidants at various stages of atherosclerosis has not been performed in the same tissue. Using the intimal lipoprotein-containing fraction of human aortic lesions, we demonstrate here that cholesterol accumulated with lesion development and that this increase was already significant at the fatty streak stage. By comparison, cholesterylesters increased significantly only in fibro-fatty and more complex lesions that also contained significantly increased amounts of cholesterylester hydro(pero)xides and 27-hydroxycholesterol. Cholesterylester hydroxides were the major lipid oxidation product detected. Despite accumulation of oxidized lipid, alpha-tocopherol was also present and maintained at a comparable level over the disease process. Of the oxidized protein moieties measured only o,o-dityrosine increased with disease, although chlorotyrosines were present at relatively high levels in all lesions compared to healthy vessels. Our data show that accumulation of nonoxidized lipid precedes that of oxidized lipid in human aortic lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11839591      PMCID: PMC1850639          DOI: 10.1016/S0002-9440(10)64890-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

1.  Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima.

Authors:  U P Steinbrecher; M Lougheed
Journal:  Arterioscler Thromb       Date:  1992-05

Review 2.  Stable markers of oxidant damage to proteins and their application in the study of human disease.

Authors:  M J Davies; S Fu; H Wang; R T Dean
Journal:  Free Radic Biol Med       Date:  1999-12       Impact factor: 7.376

3.  Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol.

Authors:  R Stocker; V W Bowry; B Frei
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

4.  A method for defining the stages of low-density lipoprotein oxidation by the separation of cholesterol- and cholesteryl ester-oxidation products using HPLC.

Authors:  L Kritharides; W Jessup; J Gifford; R T Dean
Journal:  Anal Biochem       Date:  1993-08-15       Impact factor: 3.365

5.  Lipids and oxidised lipids in human atheroma and normal aorta.

Authors:  K L Carpenter; S E Taylor; J A Ballantine; B Fussell; B Halliwell; M J Mitchinson
Journal:  Biochim Biophys Acta       Date:  1993-04-07

6.  Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages.

Authors:  L J Hazell; R Stocker
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

Review 7.  The pathogenesis of atherosclerosis: a perspective for the 1990s.

Authors:  R Ross
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

8.  Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins.

Authors:  S P Gieseg; J A Simpson; T S Charlton; M W Duncan; R T Dean
Journal:  Biochemistry       Date:  1993-05-11       Impact factor: 3.162

9.  Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation.

Authors:  U P Steinbrecher; M Lougheed; W C Kwan; M Dirks
Journal:  J Biol Chem       Date:  1989-09-15       Impact factor: 5.157

10.  Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching.

Authors:  J S Frank; A M Fogelman
Journal:  J Lipid Res       Date:  1989-07       Impact factor: 5.922

View more
  40 in total

Review 1.  The SYK side of TLR4: signalling mechanisms in response to LPS and minimally oxidized LDL.

Authors:  Yury I Miller; Soo-Ho Choi; Philipp Wiesner; Yun Soo Bae
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 2.  The role of oxysterols in vascular ageing.

Authors:  Simona Gargiulo; Paola Gamba; Gabriella Testa; Gabriella Leonarduzzi; Giuseppe Poli
Journal:  J Physiol       Date:  2016-01-19       Impact factor: 5.182

3.  Serum amyloid A in uremic HDL promotes inflammation.

Authors:  Thomas Weichhart; Chantal Kopecky; Markus Kubicek; Michael Haidinger; Dominik Döller; Karl Katholnig; Cacang Suarna; Philipp Eller; Markus Tölle; Christopher Gerner; Gerhard J Zlabinger; Markus van der Giet; Walter H Hörl; Roland Stocker; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 4.  Imaging techniques for the vulnerable coronary plaque.

Authors:  F Cademartiri; L La Grutta; A Palumbo; E Maffei; A Aldrovandi; R Malagò; F Alberghina; F Pugliese; G Runza; M Belgrano; M Midiri; M A Cova; G P Krestin
Journal:  Radiol Med       Date:  2007-07-24       Impact factor: 3.469

Review 5.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

6.  Electrospray MS/MS reveals extensive and nonspecific oxidation of cholesterol esters in human peripheral vascular lesions.

Authors:  Patrick M Hutchins; Ernest E Moore; Robert C Murphy
Journal:  J Lipid Res       Date:  2011-08-31       Impact factor: 5.922

7.  A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma.

Authors:  Ayelet Gonen; Soo-Ho Choi; Phuong Miu; Colin Agatisa-Boyle; Daniel Acks; Angela M Taylor; Coleen A McNamara; Sotirios Tsimikas; Joseph L Witztum; Yury I Miller
Journal:  J Lipid Res       Date:  2018-12-18       Impact factor: 5.922

8.  The interaction between metabolism, cancer and cardiovascular disease, connected by 27-hydroxycholesterol.

Authors:  Wan-Ru Lee; Tomonori Ishikawa; Michihisa Umetani
Journal:  Clin Lipidol       Date:  2014

9.  Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI.

Authors:  Manojkumar Valiyaveettil; Niladri Kar; Mohammad Z Ashraf; Tatiana V Byzova; Maria Febbraio; Eugene A Podrez
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

10.  Fragmentation of extracellular matrix by hypochlorous acid.

Authors:  Alan A Woods; Michael J Davies
Journal:  Biochem J       Date:  2003-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.